2020
DOI: 10.1016/j.bmc.2020.115723
|View full text |Cite
|
Sign up to set email alerts
|

Discovery and structure activity relationships of 7-benzyl triazolopyridines as stable, selective, and reversible inhibitors of myeloperoxidase

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
15
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 20 publications
(16 citation statements)
references
References 29 publications
1
15
0
Order By: Relevance
“…Likewise, similar to the reference peptides, each CS peptide could interact with 4-5 of the seven key residues in the active site of MPO. These key residues contributed to the stability of the interaction between 7-benzyl-1H-[1,2,3]triazolo[4,5-b]pyridin-5-amine, the bound inhibitor in the MPO crystal, and the active site of MPO [25]. As observed in the two reference peptides, all the five CS peptides could bind directly to the heme moiety of MPO (Table 7).…”
Section: Molecular Docking Of Peptides On Mpomentioning
confidence: 76%
See 2 more Smart Citations
“…Likewise, similar to the reference peptides, each CS peptide could interact with 4-5 of the seven key residues in the active site of MPO. These key residues contributed to the stability of the interaction between 7-benzyl-1H-[1,2,3]triazolo[4,5-b]pyridin-5-amine, the bound inhibitor in the MPO crystal, and the active site of MPO [25]. As observed in the two reference peptides, all the five CS peptides could bind directly to the heme moiety of MPO (Table 7).…”
Section: Molecular Docking Of Peptides On Mpomentioning
confidence: 76%
“…The X-ray crystal structures of murine Keap1 in complex with inhibitor RA839 (PDB code: 5CGJ) [7], human MPO bound to inhibitor 7-benzyl-1H- [1,2,3]triazolo [4,5-b]pyridin-5-amine (PDB code: 6WYD) [25], and bovine XO complexed with quercetin (PDB code: 3NVY) [26] were downloaded from the RCSB Protein Data Bank (https://www.rcsb. org) [27,28] (access date: 19 June 2021).…”
Section: Docking-based Screening Of Potential Inhibitors Of Keap1 Mpo and Xomentioning
confidence: 99%
See 1 more Smart Citation
“…LYSPH showed the strongest binding to MPO, whereas PSYLNTPLL the weakest ( Table 2 ), similar to our observations when the five peptides were docked to Keap1 ( Table 1 ). None of the peptides showed better binding affinity to MPO than did 7-benzyl-1H-[1–3]triazolo[4,5-b]pyridin-5-amine (7GD)(−7.1 kcal/mol) (data not shown), a co-crystalized inhibitor of MPO [ 41 ]. However, all five peptides could form hydrophobic interactions with one of the catalytic residues (Arg239) of MPO.…”
Section: Resultsmentioning
confidence: 99%
“…Supporting this possibility is the finding that two experimentally-validated anti-MPO peptides (TDY and FAPQY) could also bind to Arg239 and the heme group of MPO [ 43 ]. Analysis of intermolecular interactions revealed that LYSPH could form hydrophobic interactions with Phe99, Thr238, Arg239, Glu242, Phe366, Phe407, and Hec606 of MPO ( Table 2 ), resembling to the binding pattern of 7GD [ 41 ]. Hence, LYSPH is the most promising MPO inhibitor among the five peptides as it showed the best binding affinity to MPO and could interact with MPO similarly as 7GD.…”
Section: Resultsmentioning
confidence: 99%